These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


72 related items for PubMed ID: 2132633

  • 1. Water immersion (WI) induced alterations of plasma vasopressin (AVP) levels in patients with noninflammatory acute renal failure (NARF) and in patients with chronic renal failure (CRF).
    Kokot F, Grzeszczak W, Zukowska-Szczechowska E, Wiecek A.
    Mater Med Pol; 1990; 22(4):308-10. PubMed ID: 2132633
    [Abstract] [Full Text] [Related]

  • 2. Water immersion-induced alterations of plasma atrial natriuretic peptide level and its relationship to the renin-angiotensin-aldosterone system and vasopressin secretion in acute and chronic renal failure.
    Kokot F, Grzeszczak W, Zukowska-Szczechowska E, Wiecek A.
    Clin Nephrol; 1989 May; 31(5):247-52. PubMed ID: 2525441
    [Abstract] [Full Text] [Related]

  • 3. Water immersion induced alterations of plasma vasopressin levels and activity of the renin-angiotensin-aldosterone system in noninflammatory acute renal failure and end-stage renal failure.
    Kokot F, Grzeszczak W, Zukowska-Szczechowska E, Wiecek A.
    Int Urol Nephrol; 1990 May; 22(3):285-93. PubMed ID: 2210986
    [Abstract] [Full Text] [Related]

  • 4. Water immersion induced alterations of plasma adrenaline and noradrenaline levels in patients with endstage renal failure (CRF) and in healthy persons.
    Zukowska-Szczechowska E, Wocial B, Grzeszczak W, Kokot F.
    Mater Med Pol; 1989 May; 21(3):160-4. PubMed ID: 2491265
    [Abstract] [Full Text] [Related]

  • 5. Water immersion induced alterations of atrial natriuretic peptide in patients with noninflammatory acute renal failure.
    Kokot F, Grzeszczak W, Wiecek A.
    Mater Med Pol; 1989 May; 21(3):155-9. PubMed ID: 2535242
    [Abstract] [Full Text] [Related]

  • 6. [Effect of water immersion on plasma renin activity, vasopressin and aldosterone level in diabetics].
    Duława J, Kokot F, Grzeszczak W, Wiecek A.
    Z Gesamte Inn Med; 1987 Jun 01; 42(11):298-302. PubMed ID: 3310425
    [Abstract] [Full Text] [Related]

  • 7. The activity of the renin-angiotensin-aldosterone (RAA) system and vasopressin secretion in patients with acute non-inflammatory renal failure.
    Irzyniec T, Kokot F, Grzeszczak W, Klin M.
    Mater Med Pol; 1991 Jun 01; 23(2):130-5. PubMed ID: 1842599
    [Abstract] [Full Text] [Related]

  • 8. Response of plasma vasopressin to changes in extracellular volume and/or plasma osmolality in patients on maintenance hemodialysis.
    Fasanella d'Amore T, Wauters JP, Waeber B, Nussberger J, Brunner HR.
    Clin Nephrol; 1985 Jun 01; 23(6):299-302. PubMed ID: 4028528
    [Abstract] [Full Text] [Related]

  • 9. Renal response to central volume expansion induced by water immersion (WI) in heart transplant patients.
    Kokot F, Religa Z, Pasyk S, Wiecek A, Frycz J, Grzeszczak W, Bochenek A, Duława J.
    Acta Med Pol; 1989 Jun 01; 30(3-4):111-9. PubMed ID: 2535269
    [Abstract] [Full Text] [Related]

  • 10. [Effect of water immersion on levels of atrial natriuretic peptide in patients with chronic renal failure].
    Zukowska-Szczechowska E, Kokot F, Grzeszczak W, Wiecek A.
    Pol Tyg Lek; 1989 Jun 01; 44(36-39):839-42. PubMed ID: 2535018
    [Abstract] [Full Text] [Related]

  • 11. Water immersion-induced endocrine alterations in women with EPH gestosis.
    Doniec-Ulman I, Kokot F, Wambach G, Drab M.
    Clin Nephrol; 1987 Aug 01; 28(2):51-5. PubMed ID: 2958200
    [Abstract] [Full Text] [Related]

  • 12. Platelet vasopressin receptor in patients with chronic renal failure.
    Inaba K, Umeda Y, Yamane Y, Urakami M, Nagata T, Inada M.
    Nihon Jinzo Gakkai Shi; 1989 Oct 01; 31(10):1079-84. PubMed ID: 2533288
    [Abstract] [Full Text] [Related]

  • 13. [The influence of opioid receptor blockade on the behavior of selected biochemical and hormonal parameters in patients with renovascular hypertension studied under water immersion conditions].
    Baczyński R, Kokot F.
    Przegl Lek; 1995 Oct 01; 52(6):297-302. PubMed ID: 7568983
    [Abstract] [Full Text] [Related]

  • 14. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F, Floridi AG, Floridi A, Buoncristiani U.
    Clin Nutr; 2004 Apr 01; 23(2):205-12. PubMed ID: 15030960
    [Abstract] [Full Text] [Related]

  • 15. Influence of naloxone on prolactin secretion in patients with acute and chronic renal failure.
    Grzeszczak W, Kokot F, Dulawa J.
    Clin Nephrol; 1984 Jan 01; 21(1):47-9. PubMed ID: 6705273
    [Abstract] [Full Text] [Related]

  • 16. Hemodilution, vasopressin suppression, and diuresis during water immersion in man.
    Greenleaf JE, Shevartz E, Keil LC.
    Aviat Space Environ Med; 1981 Jun 01; 52(6):329-36. PubMed ID: 7259690
    [Abstract] [Full Text] [Related]

  • 17. Osmoregulation of vasopressin release and gene transcription under acute and chronic hypovolemia in rats.
    Kondo N, Arima H, Banno R, Kuwahara S, Sato I, Oiso Y.
    Am J Physiol Endocrinol Metab; 2004 Mar 01; 286(3):E337-46. PubMed ID: 14613925
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 01; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.